Overweight, Obesity Increase Risk of Carpal Tunnel Syndrome

This article originally appeared here.
Share this content:
Overweight, Obesity Increase Risk of Carpal Tunnel Syndrome
Overweight, Obesity Increase Risk of Carpal Tunnel Syndrome

MONDAY, Sept. 28, 2015 (HealthDay News) -- Overweight and obesity are associated with increased risk of carpal tunnel syndrome (CTS), according to a meta-analysis published online Sept. 23 in Obesity Reviews.

Rahman Shiri, M.D, Ph.D., M.P.H., from the Finnish Institute of Occupational Health in Helsinki, and colleagues examined the association between overweight/obesity and CTS, and whether sex modifies the correlation. A meta-analysis was performed on 58 studies involving 1,379,372 individuals.

The researchers found that the risk of CTS or carpal tunnel release was increased with overweight and obesity (pooled confounder-adjusted odds ratios, 1.47 and 2.02, respectively). The risk of CTS was increased by 7.4 percent for every one-unit increase in body mass index (adjusted odds ratio, 1.074). The effects of overweight and obesity were stronger on carpal tunnel release than CTS. The correlations did not differ for men and women and were not affected by study design.

"As the prevalence of overweight and obesity is increasing globally, overweight-related CTS is expected to increase," the authors write. "Future studies should investigate whether a square-shaped wrist and exposure to physical workload factors potentiate the adverse effect of obesity on the median nerve."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »